| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.13 | 0.6 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.035 | 0.6 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.6 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.039 | 0.6 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |